{{Rsnum
|rsid=10521792
|Gene=FGF13
|Chromosome=X
|position=139035247
|Orientation=plus
|GMAF=0.1638
|Gene_s=FGF13
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 86.2 | 6.2 | 7.7
| HCB | 93.3 | 4.4 | 2.2
| JPT | 94.5 | 2.7 | 2.7
| YRI | 63.5 | 22.2 | 14.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 93.3 | 4.4 | 2.2
| CHD | 86.0 | 7.5 | 6.5
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 90.9 | 3.0 | 6.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=2E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}